Figure 1

Figure 1. From: Phase 1 Study of Pazopanib in Patients with Advanced Solid Tumors and Hepatic Dysfunction: A National Cancer Institute Organ Dysfunction Working Group Study.

Average steady-state pazopanib plasma concentration versus time plots measured during the week 3 expansion phase

Stephen I Shibata, et al. Clin Cancer Res. ;19(13):3631-3639.

Supplemental Content

Filter your results:

Search details

See more...

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...
Write to the Help Desk